Sign inGet started

SCTX

Scribe Therapeutics, Inc.CIK 1853921 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
13

AI insights for SCTX PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for SCTX
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Avoro Ventures LLCDirector4$36.26M$02026-07-28
Aghazadeh BehzadDirector, 10% Owner, Other3$36.26M$02026-07-28
Doudna Jennifer A10% Owner4$0$02026-07-27
AH Equity Partners Bio II, L.L.C.10% Owner5$5.00M$02026-07-27
AH Bio Fund II, L.P.10% Owner5$5.00M$02026-07-27
GORDON CARL LDirector7$30.00M$02026-07-27
ORBIMED ADVISORS LLCDirector6$30.00M$02026-07-27
Staahl Brett10% Owner6$0$02026-07-23
Watson James DeanDirector1$0$02026-07-23
Parrot DavidChief Financial Officer5$40.0K$02026-07-23
Oakes Benjamin L.President, CEO3$0$02026-07-23
Bleharski JoshuaDirector1$0$02026-07-23
Lucas SvetlanaChief Business Officer4$45.0K$02026-07-23

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Avoro Ventures LLCDirector P Buy2026-07-282026-07-287,905$18.25 $144.3K3,088,888SEC↗
Aghazadeh BehzadDirector, 10% Owner, Other P Buy2026-07-282026-07-287,905$18.25 $144.3K3,088,888SEC↗
Doudna Jennifer A10% Owner C Conversion deriv2026-07-272026-07-2974,088— $00SEC↗
ORBIMED ADVISORS LLCDirector C Conversion deriv2026-07-272026-07-292,065,672— $00SEC↗
GORDON CARL LDirector C Conversion deriv2026-07-272026-07-292,065,672— $00SEC↗
AH Equity Partners Bio II, L.L10% Owner C Conversion deriv2026-07-272026-07-2912,150,003— $00SEC↗
AH Equity Partners Bio II, L.L10% Owner C Conversion deriv2026-07-272026-07-294,131,344— $00SEC↗
Doudna Jennifer A10% Owner C Conversion2026-07-272026-07-2912,511— $0603,547SEC↗
ORBIMED ADVISORS LLCDirector C Conversion2026-07-272026-07-29348,825— $0348,825SEC↗
ORBIMED ADVISORS LLCDirector P Buy2026-07-272026-07-291,000,000$15.00 $15.00M1,348,825SEC↗
GORDON CARL LDirector C Conversion2026-07-272026-07-29348,825— $0348,825SEC↗
GORDON CARL LDirector P Buy2026-07-272026-07-291,000,000$15.00 $15.00M1,348,825SEC↗
AH Equity Partners Bio II, L.L10% Owner C Conversion2026-07-272026-07-292,051,742— $02,051,742SEC↗
AH Equity Partners Bio II, L.L10% Owner C Conversion2026-07-272026-07-29697,650— $0697,650SEC↗
AH Equity Partners Bio II, L.L10% Owner P Buy2026-07-272026-07-29333,333$15.00 $5.00M2,385,075SEC↗
ORBIMED ADVISORS LLCDirector C Conversion deriv2026-07-272026-07-292,065,672— $00SEC↗
ORBIMED ADVISORS LLCDirector P Buy2026-07-272026-07-291,000,000$15.00 $15.00M1,348,825SEC↗
ORBIMED ADVISORS LLCDirector C Conversion2026-07-272026-07-29348,825— —348,825SEC↗
GORDON CARL LDirector C Conversion deriv2026-07-272026-07-292,065,672— $00SEC↗
GORDON CARL LDirector P Buy2026-07-272026-07-291,000,000$15.00 $15.00M1,348,825SEC↗
GORDON CARL LDirector C Conversion2026-07-272026-07-29348,825— —348,825SEC↗
Doudna Jennifer A10% Owner C Conversion deriv2026-07-272026-07-2974,088— —0SEC↗
Doudna Jennifer A10% Owner C Conversion2026-07-272026-07-2912,511— —603,547SEC↗
AH Bio Fund II, L.P.10% Owner C Conversion deriv2026-07-272026-07-294,131,344— $00SEC↗
AH Bio Fund II, L.P.10% Owner C Conversion deriv2026-07-272026-07-2912,150,003— $00SEC↗
AH Bio Fund II, L.P.10% Owner P Buy2026-07-272026-07-29333,333$15.00 $5.00M2,385,075SEC↗
AH Bio Fund II, L.P.10% Owner C Conversion2026-07-272026-07-29697,650— —697,650SEC↗
AH Bio Fund II, L.P.10% Owner C Conversion2026-07-272026-07-292,051,742— —2,051,742SEC↗
Avoro Ventures LLCDirector P Buy2026-07-242026-07-282,333,333$15.00 $35.00M3,030,983SEC↗
Avoro Ventures LLCDirector P Buy2026-07-242026-07-2850,000$22.31 $1.12M3,080,983SEC↗
Aghazadeh BehzadDirector, 10% Owner, Other P Buy2026-07-242026-07-2850,000$22.31 $1.12M3,080,983SEC↗
Aghazadeh BehzadDirector, 10% Owner, Other P Buy2026-07-242026-07-282,333,333$15.00 $35.00M3,030,983SEC↗
Avoro Ventures LLCDirector A Award deriv2026-07-232026-07-2714,725— $014,725SEC↗
Parrot DavidChief Financial Officer A Award deriv2026-07-232026-07-27109,426— $0109,426SEC↗
Parrot DavidChief Financial Officer A Award deriv2026-07-232026-07-27109,426— $0109,426SEC↗
Bleharski JoshuaDirector A Award deriv2026-07-232026-07-2714,725— $014,725SEC↗
Watson James DeanDirector A Award deriv2026-07-232026-07-2714,725— $014,725SEC↗
GORDON CARL LDirector A Award deriv2026-07-232026-07-2714,725— $014,725SEC↗
Oakes Benjamin L.President, CEO A Award deriv2026-07-232026-07-27429,599— $0429,599SEC↗
Oakes Benjamin L.President, CEO A Award deriv2026-07-232026-07-27264,784— $0264,784SEC↗
Lucas SvetlanaChief Business Officer A Award deriv2026-07-232026-07-27109,426— $0109,426SEC↗
Lucas SvetlanaChief Business Officer A Award deriv2026-07-232026-07-27109,426— $0109,426SEC↗
Staahl Brett10% Owner A Award deriv2026-07-232026-07-2819,385— $019,385SEC↗
Staahl Brett10% Owner A Award deriv2026-07-232026-07-2819,385— $019,385SEC↗
Parrot DavidChief Financial Officer P Buy2026-07-232026-07-271,333$15.00 $20.0K1,333SEC↗
Parrot DavidChief Financial Officer P Buy2026-07-232026-07-271,333$15.00 $20.0K1,333SEC↗
Lucas SvetlanaChief Business Officer P Buy2026-07-232026-07-273,000$15.00 $45.0K3,000SEC↗
Staahl Brett10% Owner A Award deriv2026-07-232026-07-2819,385— $019,385SEC↗
Staahl Brett10% Owner A Award deriv2026-07-232026-07-2819,385— $019,385SEC↗
Parrot DavidChief Financial Officer A Award deriv2026-03-132026-07-278,909— $08,909SEC↗
Oakes Benjamin L.President, CEO A Award deriv2026-03-132026-07-2712,969— $012,969SEC↗
Lucas SvetlanaChief Business Officer A Award deriv2026-03-132026-07-279,547— $09,547SEC↗
Staahl Brett10% Owner A Award deriv2026-03-132026-07-284,755— $04,755SEC↗
Staahl Brett10% Owner A Award deriv2026-03-132026-07-284,755— $04,755SEC↗